Welcome to our dedicated page for Alphatec Hldgs news (Ticker: ATEC), a resource for investors and traders seeking the latest updates and insights on Alphatec Hldgs stock.
Alphatec Holdings, Inc. (Nasdaq: ATEC) is a spine-focused medical device company whose news flow centers on spine surgery innovation, financial performance, and strategic collaborations. Through subsidiaries such as Alphatec Spine, Inc., EOS imaging S.A.S., and SafeOp Surgical, Inc., ATEC regularly issues updates on procedural technologies, imaging platforms, and neuro-monitoring systems that support its goal of revolutionizing spine surgery.
Investors and clinicians following ATEC news can expect frequent announcements of quarterly and annual financial results, including commentary on surgical revenue, EOS revenue, adjusted EBITDA, and free cash flow. The company often pairs its earnings releases with updated full-year outlooks, highlighting trends in surgical volume growth, new surgeon adoption, and the performance of its procedural ecosystems such as PTP™ and LTP™.
ATEC’s news stream also features product and platform launches, such as the commercial introduction of the PTP™ Corpectomy system, which expands its Prone TransPsoas approach to complex thoracolumbar pathologies. These announcements provide detail on systems like the Sigma™ LIF Corpectomy Access System, Ascend™ NanoTec™ Vertebral Body Replacement System, and SafeOp™ Neural InformatiX™ System, illustrating how the company integrates access, implants, and neuro-monitoring into a unified procedural offering.
Strategic and corporate developments are another recurring theme. Recent news includes a definitive partnership with Theradaptive, Inc. granting ATEC exclusive U.S. commercial rights to OsteoAdapt®, an osteoinductive bone graft for spinal fusion built on AMP2™ protein technology. The company also issues releases about participation in major healthcare and medtech conferences, board-related updates, and inducement equity awards for new employees. This news page aggregates these items so readers can track how ATEC’s spine-only strategy, innovation pipeline, and financial trajectory evolve over time.
Alphatec Holdings, Inc. (ATEC) reported a strong 43% growth in total revenue, reaching $90 million for Q3 2022, driven by a 53% increase in surgical revenue. The company achieved a 66% GAAP gross margin and a 71% non-GAAP gross margin. Despite operating expenses of $94 million, adjusted EBITDA improved significantly, with a margin increase of 870 basis points year-over-year. ATEC anticipates total revenue of $340 million for the full year, in line with a 40% growth rate forecasted earlier.
Alphatec Holdings, Inc. (NASDAQ: ATEC) announced participation in several investor events aimed at discussing spine surgery innovations. Key events include a fireside chat at the Stifel 2022 Healthcare Conference on November 15, 2022, and the Jefferies London Healthcare Conference on November 17, 2022. Additionally, ATEC will present at the Piper Sandler Healthcare Conference on November 30, 2022, and host a visit from the Stifel Medtech Madness Annual West Coast Bus Tour on December 12, 2022. Webcasts and archived recordings will be accessible on the Investor Relations section of ATEC's website.
Alphatec Holdings, Inc. (ATEC) announced its participation in the 2022 NASS Annual Meeting, where it will unveil its new expandable interbody and access technology aimed at enhancing minimally-invasive spine surgery. This innovative approach minimizes muscle damage and blood loss, leading to shorter hospital stays and quicker recovery for patients. The Sigma Medialized Access System and PSX Expandable Interbody Implant System are designed to improve surgical outcomes by allowing precise control of spinal alignment and disc height restoration.
Alphatec Holdings, Inc. (NASDAQ: ATEC) has unveiled innovative advancements in its lateral spine surgery techniques at the 2022 NASS Annual Meeting. This includes enhancements to its Lateral TransPsoas (LTPTM) and Midline ALIFTM approaches, designed to improve patient outcomes and streamline surgical procedures. Key features involve a novel positioner and retractor integrated with SafeOp Neuromonitoring technology, aimed at minimizing complications during surgery. The company emphasizes its commitment to becoming a standard bearer in less invasive spine care.
Alphatec Holdings (NASDAQ: ATEC) reported preliminary financial results for Q3 2022, projecting total revenues between
Alphatec Holdings (NASDAQ: ATEC) announced its participation in the North American Spine Society (NASS) 37th Annual Meeting from October 12-15, 2022. The company will showcase its innovative spine surgery solutions, emphasizing advancements in lateral access surgery, including the Prone TransPsoas (PTP™) approach. Key presentations include topics on clinical distinction and the use of EOS imaging. The event aims to demonstrate how ATEC enhances clinical predictability and reproducibility in spine surgery. CEO Pat Miles expressed enthusiasm for their progress and future innovations.
Alphatec Holdings, Inc. (Nasdaq: ATEC) announced participation in three upcoming investor events. CFO Todd Koning and VP of Finance Robert Judd will engage in a fireside chat at the H.C. Wainwright 24th Annual Global Investment Conference on September 12, 2022, at 5:00 p.m. ET. They will also participate in the Morgan Stanley 20th Annual Global Healthcare Conference on September 13, 2022, at 4:05 p.m. ET, and the Lake Street Big 6 Conference on September 14, 2022. Webcasts will be available in the Investor Relations Section of the Company’s website.
Alphatec Holdings, Inc. (ATEC) reported a 35% increase in total revenue to $84 million for Q2 2022, with organic growth of 30%. The GAAP gross margin was 66%, and the company reported an operating loss of $36 million. Notably, EOS imaging contributed $12 million in revenue, a 49% growth. ATEC raised its full-year revenue guidance to $325 million, reflecting an anticipated 34% growth. The firm hosted over 150 surgeons, increasing users by 23%, alongside a 10% increase in average revenue per surgery.
Alphatec Holdings, Inc. (NASDAQ: ATEC) will participate in several investor events, featuring CEO Pat Miles and CFO Todd Koning. Key events include the 42nd Annual Canaccord Genuity Growth Conference on August 10, 2022, and the 7th Annual Needham Virtual MedTech and Diagnostics 1x1 Conference on August 15, 2022. Additionally, they will join the Piper Sandler MedTech and Diagnostics West Coast Bus Tour and the RBC West Coast Medical Device Bus Tour, both on August 23, 2022. Webcasts of these events will be available in the Investor Relations Section of ATEC's website.
Alphatec Holdings, Inc. (NASDAQ: ATEC) will report its second quarter 2022 financial results on August 4, 2022, after market close. A live webcast for this event will occur at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties can access the webcast through the Investor Relations Section of ATEC's website. Call-in details for participation will also be provided before the event.